EFFECTS OF INTRAPERITONEAL CYCLOOXYGENASE INHIBITION ON INFLAMMATORY MEDIATORS IN DIALYSATE AND PERITONEAL MEMBRANE-CHARACTERISTICS DURING PERITONITIS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
D. Zemel et al., EFFECTS OF INTRAPERITONEAL CYCLOOXYGENASE INHIBITION ON INFLAMMATORY MEDIATORS IN DIALYSATE AND PERITONEAL MEMBRANE-CHARACTERISTICS DURING PERITONITIS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, The Journal of laboratory and clinical medicine, 126(2), 1995, pp. 204-215
Citations number
64
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
Peritonitis complicating continuous ambulatory peritoneal dialysis (CA
PD) can be used as an in vivo model to study the contribution of media
tors in dialysate to the regulation of peritoneal permeability. Previo
usly we reported that changes in the peritoneal appearance rates of th
e cytokines interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF
alpha) were related to alterations in the effective peritoneal surface
area. Changes in the intrinsic peritoneal permeability were mainly re
lated to those in the peritoneal appearance rate of the prostanoid pro
staglandin E(2) (PGE(2)) and partly also to that of IL-6. In this inte
rvention study the role of these mediators was further analyzed. Eleve
n peritonitis episodes were followed on 8 consecutive days from the st
art of the infection and once oner recovery. Indomethacin was given in
traperitoneally during the first 3 days. beta(3)-Microglobulin clearan
ce was used as indicator of the effective peritoneal surface area. The
intrinsic peritoneal permeability was characterized functionally by t
he restriction coefficient. The 15 peritonitis episodes studied previo
usly served as the control group. This study supports the formerly obt
ained relationships in two ways. First, significant reductions were ob
served for peritoneal PGE(2), 6-keto-PGF(1 alpha), and TxB(2) during c
yclooxygenase inhibition to 6%, 0.6%, and 9% of the values on day 1, w
hereas simultaneously the intrinsic permeability was less increased. T
his indomethacin effect on intrinsic permeability was not entirely sig
nificant, probably because of the additional role of IL-6, which was n
ot influenced by indomethacin. Also, the appearance rate of TNF alpha
in the effluent was not affected by cyclooxygenase inhibition. Accordi
ngly, the changes in the effective surface area were similar to those
in the control group. Second, in 8 of the 11 cases, new rises both in
peritoneal PGE, and in intrinsic permeability occurred after discontin
uation of indomethacin. Rebounds were not seen for TNF alpha or IL-6,
and, consistently, not for the effective surface area. In conclusion,
local cyclooxygenase inhibition results in a less-increased intrinsic
permeability during peritonitis but has no effect on the effective sur
face area. These data support our previous finding that IL-6 and TNF a
lpha contribute to alterations in surface area, whereas PGE(2) is more
involved in intrinsic peritoneal permeability changes,